Medartis Holding AG

MED.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MED.SW stands at 999.6M. In comparison, ABT.SW has a market cap of 146.8B. Regarding current trading prices, MED.SW is priced at CHF 81.60, while ABT.SW trades at CHF 84.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MED.SW currently has a P/E ratio of 120.00, whereas ABT.SW's P/E ratio is 28.64. In terms of profitability, MED.SW's ROE is +0.03%, compared to ABT.SW's ROE of +0.13%. Regarding short-term risk, MED.SW is more volatile compared to ABT.SW. This indicates potentially higher risk in terms of short-term price fluctuations for MED.SW.Check ABT.SW's competition here

MED.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MED.SW stands at 999.6M. In comparison, ZBH.SW has a market cap of 13.2B. Regarding current trading prices, MED.SW is priced at CHF 81.60, while ZBH.SW trades at CHF 67.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MED.SW currently has a P/E ratio of 120.00, whereas ZBH.SW's P/E ratio is 24.19. In terms of profitability, MED.SW's ROE is +0.03%, compared to ZBH.SW's ROE of +0.06%. Regarding short-term risk, MED.SW is more volatile compared to ZBH.SW. This indicates potentially higher risk in terms of short-term price fluctuations for MED.SW.Check ZBH.SW's competition here

MED.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MED.SW stands at 999.6M. In comparison, SOON.SW has a market cap of 10.7B. Regarding current trading prices, MED.SW is priced at CHF 81.60, while SOON.SW trades at CHF 179.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MED.SW currently has a P/E ratio of 120.00, whereas SOON.SW's P/E ratio is 20.56. In terms of profitability, MED.SW's ROE is +0.03%, compared to SOON.SW's ROE of +0.20%. Regarding short-term risk, MED.SW is more volatile compared to SOON.SW. This indicates potentially higher risk in terms of short-term price fluctuations for MED.SW.Check SOON.SW's competition here

MED.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MED.SW stands at 999.6M. In comparison, MOVE.SW has a market cap of 3.1B. Regarding current trading prices, MED.SW is priced at CHF 81.60, while MOVE.SW trades at CHF 153.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MED.SW currently has a P/E ratio of 120.00, whereas MOVE.SW's P/E ratio is 35.29. In terms of profitability, MED.SW's ROE is +0.03%, compared to MOVE.SW's ROE of +0.22%. Regarding short-term risk, MED.SW is more volatile compared to MOVE.SW. This indicates potentially higher risk in terms of short-term price fluctuations for MED.SW.Check MOVE.SW's competition here